Quickly find information on which generic drugs can be safely substituted for brand name drugs, important compounding information, drugs that have been discontinued, orphan drugs, purity and storage standards, as well as a manufacturer listing with their approved drugs.
This valuable reference includes the complete contents of the FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. It also features excerpts from USP-NF regarding quality, packaging, storing and labeling requirements, and color pill charts can help you quickly identify pills and capsules.
USP DI® Drug Reference Guides
Impartial, consensus-based resources to help answer your drug information needs
Obtaining drug information has become easier, but ensuring the accuracy of that information is not necessarily as easy. USP DI® Drug Reference Guides are compiled and reviewed by USP Advisory Panels comprising over 800 volunteer healthcare experts. Impartial, consensus-based, and reliable, USP DI drug information is subject to external/public review by hundreds of individuals from medical, pharmacy, nursing, and dental schools; state and national medical and pharmacy organizations; consumer groups; government agencies; and manufacturers. Only USP DI drug data undergoes such an intensive review process, which means you can use USP references with complete confidence.
Available USP DI® Drug Reference Guides:
- Volume I: Drug Information for the Health Care Professional
- Volume II: Advice for the Patient®
- Volume III: Approved Drug Products and Legal Requirements
- USP DI Volumes I and II are available through MICROMEDEX® Healthcare Series, in printed books, or on the Desktop Series CD-ROM. USP DI Volume III is available in a printed book only.
USP DI® Drug Reference Guides are ideal for…
- Pharmacists, physicians, nurses, and all healthcare professionals
- Professional and consumer healthcare websites
- Pharmacy, hospital, and physician information systems
- Medical school faculty, students, and libraries
Why you need USP DI Reference Guides…
- Provides a U.S. federal government-recognized resource for drug utilization review (DUR), unlabeled use reimbursement, and patient education
- Contains current, accurate, in-depth data thoroughly reviewed, evaluated, and updated by clinical experts
- Offers a variety of electronic licensing opportunities enabling easy integration into a variety of applications
- Presents data relied upon and respected among international healthcare organizations and educators
